Are cytokine responses in renal cell cancer the product of placebo effect of treatment or true biotherapy? What trials are needed now? (Q41888226)

From Wikidata

Jump to navigation Jump to search

scientific article published on April 1998

edit

Language	Label	Description	Also known as
English	Are cytokine responses in renal cell cancer the product of placebo effect of treatment or true biotherapy? What trials are needed now?	scientific article published on April 1998

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PMC publication ID

2150173

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9579839%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 November 2019

review article

1 reference

stated in

PubMed

retrieved

20 November 2019

program comment

1 reference

PubMed publication ID

9579839

title

Are cytokine responses in renal cell cancer the product of placebo effect of treatment or true biotherapy? What trials are needed now? (English)

1 reference

stated in

Europe PubMed Central

PMC publication ID

2150173

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9579839%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 November 2019

main subject

renal cell carcinoma

1 reference

stated in

PubMed

retrieved

20 November 2019

kidney neoplasm

1 reference

stated in

PubMed

retrieved

20 November 2019

interferon-alpha

1 reference

stated in

PubMed

retrieved

20 November 2019

placebo

1 reference

based on heuristic

inferred from title

interleukin-2

1 reference

PubMed publication ID

9579839

placebo effect

1 reference

based on heuristic

inferred from title

author

Tim Oliver

series ordinal

1

1 reference

stated in

Europe PubMed Central

PMC publication ID

2150173

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9579839%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 November 2019

author name string

Oliver RT

series ordinal

1

1 reference

stated in

Europe PubMed Central

PMC publication ID

2150173

retrieved

13 October 2017

language of work or name

English

0 references

publication date

1 April 1998

4 references

stated in

PubMed Central

retrieved

3 April 2019

stated in

Europe PubMed Central

PMC publication ID

2150173

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9579839%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 November 2019

stated in

PubMed Central

retrieved

20 November 2019

stated in

PubMed Central

retrieved

29 May 2020

published in

British Journal of Cancer

4 references

stated in

PubMed Central

retrieved

3 April 2019

stated in

Europe PubMed Central

PMC publication ID

2150173

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9579839%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 November 2019

stated in

PubMed Central

retrieved

20 November 2019

stated in

PubMed Central

retrieved

29 May 2020

volume

77

1 reference

stated in

Europe PubMed Central

PMC publication ID

2150173

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9579839%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 November 2019

issue

8

1 reference

stated in

Europe PubMed Central

PMC publication ID

2150173

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9579839%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 November 2019

page(s)

1318-1320

1 reference

stated in

Europe PubMed Central

PMC publication ID

2150173

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9579839%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 November 2019

cites work

Aldesleukin (recombinant interleukin-2): a review of its pharmacological properties, clinical efficacy and tolerability in patients with renal cell carcinoma

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150173

retrieved

5 June 2018

Survival in renal cell carcinoma-a randomized evaluation of tamoxifen vs interleukin 2, alpha-interferon (leucocyte) and tamoxifen

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150173

retrieved

5 June 2018

Correlation between clinical response to interleukin 2 and HLA phenotypes in patients with metastatic renal cell carcinoma

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150173

retrieved

5 June 2018

Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150173

retrieved

5 June 2018

A phase II study of interferon-alpha, interleukin-2 and 5-fluorouracil in advanced renal carcinoma: clinical data and laboratory evidence of protease activation.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150173

retrieved

5 June 2018

On the development of the Medical Research Council trial of alpha-interferon in metastatic renal carcinoma. Urological Working Party Renal Carcinoma Subgroup

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150173

retrieved

5 June 2018

Interleukin-2. A review of its pharmacological properties and therapeutic use in patients with cancer

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150173

retrieved

5 June 2018

Deprivation and survival from breast cancer.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150173

retrieved

5 June 2018

The frequency of major histocompatibility complex antigen abnormalities in urological tumours and their correction by gene transfection or cytokine stimulation

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150173

retrieved

5 June 2018

Tuberculosis and migration. The Mitchell Lecture 1994

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150173

retrieved

5 June 2018

Interleukin-2 based home therapy of metastatic renal cell carcinoma: risks and benefits in 215 consecutive single institution patients

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150173

retrieved

5 June 2018

Proceedings: Hormone-induced and spontaneous regression of metastatic renal cancer.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150173

retrieved

5 June 2018

An assessment of the current use of human interferons in therapy of urological cancers

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150173

retrieved

5 June 2018

Effect of autolymphocyte therapy on survival and quality of life in patients with metastatic renal-cell carcinoma

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150173

retrieved

5 June 2018

Phase I study comparing continuous infusion of recombinant interleukin-2 by subcutaneous or intravenous administration

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150173

retrieved

5 June 2018

Resection of the stomach with grafting of a short antiperistaltic segment from the small intestine

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9579839

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A prospective study of the intake of vitamins C, E, and A and the risk of breast cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9579839

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Experience with the use of high-dose interleukin-2 in the treatment of 652 cancer patients

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9579839

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Unexplained spontaneous regression and alpha-interferon as treatment for metastatic renal carcinoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9579839

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Psychological support for cancer patients

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9579839

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Renal cell cancer: is there long-term survival advantage from cytokine treatment?

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9579839

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1038/BJC.1998.219

1 reference

stated in

Europe PubMed Central

PMC publication ID

2150173

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9579839%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 November 2019

PMC publication ID

2150173

1 reference

stated in

Europe PubMed Central

PMC publication ID

2150173

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9579839%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 November 2019

PubMed publication ID

9579839

1 reference

stated in

Europe PubMed Central

PMC publication ID

2150173

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9579839%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 November 2019

ResearchGate publication ID

13703903

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41888226&oldid=2204831902"